Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbott, abetted, ABX, accident, accommodate, affiliate, Affiliated, aForm, AG, AICPA, aided, Albright, Almac, anthrax, antibiotic, aprotinin, Arpida, AU, automobile, bacteremia, bacteria, bacterial, bacteriostatic, bankruptcy, Basilea, batch, biological, biopharmaceutical, Boxford, branded, bullet, calendar, Cambridge, cardiologist, Caruso, Catalent, ceftobiprole, cephalexin, certified, Civ, Clostidium, clostridium, COBRA, College, combat, compelling, compromised, confirmatory, consideration, contamination, contemplated, corroborated, County, cSSSI, cSSTI, Cubist, Curacyte, dalbavancin, daptomycin, diarrhea, difficile, difficultly, diligently, disagree, discontinuation, dividend, elinogrel, embolism, enalaprilat, engineering, enjoining, entirety, entry, environment, environmental, exceed, FAS, FASBEITF, fiduciary, fourteen, FSPNo, fungible, geographic, German, GmbH, guide, Haupt, hydralazine, ICH, iclaprim, ICU, identical, Indiana, inEITF, infection, influence, influenced, infrequent, inhalation, Injunction, injunctive, injury, inRule, insolvency, intensified, InterMune, interval, intracerebral, invoice, ischemia, issuable, IssueNo, itsSchedule, joint, Juan, kill, Latin, lawsuit, Leipzig, liable, licensee, lifecycle, linezolid, lipoglycopeptide, loan, lowest, lump, MAA, Martin, Matthew, memorandum, MERCURY, merger, merit, methicillin, Monarch, Monteverde, Montreal, motion, MOU, moxifloxacin, MRSA, multi, Munich, necessitate, network, nongovernmental, obsolescence, ofEITF, offeror, ofForm, older, onForm, orderly, oritavancin, outlook, outplacement, overcome, penalized, Pharmaceutica, pharmacokinetic, Portola, PositionEITF, preclinical, promising, promptly, PRONTO, protease, PTS, purported, QT, radioactive, recruiting, reevaluate, reformulate, relief, relocated, relocation, remove, rental, rescinding, rescissory, retrospectively, revert, rid, Rome, salary, SAS, scenario, scrupulously, Sepracor, serine, SIMPLFI, skin, soft, spectrum, SPRINT, ST, STEMI, storing, strive, subgroup, sublease, subleasing, sublimit, successor, Suffolk, switching, tangible, Targanta, teicoplanin, telavancin, temporarily, tender, tendered, Theravance, tissue, toForm, uncured, unique, unobservable, unpaid, uptake, vancomycin, version, viability, vigorously, Vito, waste, wrongful
Removed:
accelerating, acceleration, anticipation, Antinori, applied, assigned, atrial, attempt, Avenue, broadly, Cardene, clearance, coaching, consistently, driven, establishment, examine, expired, fibrillation, forma, frequent, Hill, Imagery, MA, maturation, occupy, organizational, par, partly, Paul, precise, pro, Prospect, Realty, registration, reproducible, retail, Rule, safely, serve, thirty, Unaudited, vendor, Warrant
Filing tables
Filing exhibits
- 10-K Annual report
- 10.18 EX-10.18: Lease
- 10.24 EX-10.24: Form of Amended and Restated Management Severance Agreement
- 10.25 EX-10.25: Form of Amended and Restated Management Severance Agreement
- 10.38 EX-10.38: Amendment NO.2 to License Agreement
- 10.40 EX-10.40: Amendment to Lease
- 10.42 EX-10.42: Severance Agreement
- 21 EX-21: Subsidiaries
- 23 EX-23: Consent of Ernst & Young LLP
- 31.1 EX-31.1: Certification
- 31.2 EX-31.2: Certification
- 32.1 EX-32.1: Certification
- 32.2 EX-32.2: Certification
Related press release
MDCO similar filings
Filing view
External links
Exhibit 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Forms S-8 No. 333-44884, 333-74612, 333-98191, 333-116295, 333-135460, 333-135461, 333-148602, 333-152105, 333-157499) pertaining to the 1998 Stock Incentive Plan, the 2000 Outside Director Stock Option Plan, the 2000 Employee Stock Purchase Plan, the 2001 Non-Officer, Non-Director Employee Stock Incentive Plan, the 2004 Stock Incentive Plan, the 2007 Equity Inducement Plan and the 2009 Equity Inducement Plan of The Medicines Company and Registration Statement (Form S-3 No. 333-139987) of our reports dated February 25, 2009 with respect to the consolidated financial statements and schedule of The Medicines Company and the effectiveness of internal control over financial reporting of The Medicines Company included in this Annual Report (Form 10-K) for the year ended December 31, 2008.
/s/ Ernst & Young LLP
MetroPark, NJ
February 25, 2009
MetroPark, NJ
February 25, 2009